Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.17 | -$0.10 | -$0.12 |
| Q2 2026 | 3 | -$0.06 | -$0.05 | -$0.06 |
| Q3 2026 | 4 | -$0.07 | -$0.05 | -$0.06 |
| Q4 2026 | 4 | -$0.08 | -$0.05 | -$0.06 |
| Q1 2027 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2027 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
InflaRx N.V. last posted its earnings results on Thursday, August 6th, 2026. The company reported $-0.11 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06662 by $0.04338. The company had revenue of 0 for the quarter and had revenue of 29.33 K for the year. InflaRx N.V. has generated $-1 earnings per share over the last year ($-0.66 diluted earnings per share) and currently has a price-to-earnings ratio of -3.68. InflaRx N.V. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$0.07 | -$0.09 | -0.02 | $5.24 K | $0 |
| 05/06/2026 | Q1 2026 | N/A | -$0.08 | N/A | $7.84 K | $0 |
| 03/19/2026 | Q4 2025 | -$0.18 | -$0.14 | 0.04 | $69.05 K | $-33,931 |
| 11/10/2025 | Q3 2025 | -$0.16 | -$0.18 | -0.02 | $57.33 K | $23.83 K |
| 08/07/2025 | Q2 2025 | -$0.24 | -$0.21 | 0.03 | $134.83 K | $39.43 K |
| 05/07/2025 | Q1 2025 | -$0.18 | -$0.13 | 0.05 | $82.29 K | $0 |
| 03/20/2025 | Q4 2024 | -$0.27 | -$0.09 | 0.18 | $62.36 K | $-423 |
| 11/08/2024 | Q3 2024 | -$0.27 | -$0.30 | -0.03 | $1.23 M | $123.82 K |
| 08/08/2024 | Q2 2024 | -$0.21 | -$0.24 | -0.03 | $1.31 M | $6.36 K |
| 05/08/2024 | Q1 2024 | -$0.24 | -$0.16 | 0.08 | $2.35 M | $36.04 K |
| 03/21/2024 | Q4 2023 | -$0.20 | -$0.26 | -0.06 | $2.30 M | $2.29 K |
| 11/01/2023 | Q3 2023 | -$0.29 | -$0.13 | 0.16 | $226.89 K | $60.80 K |
| 06/30/2023 | Q2 2023 | N/A | -$0.14 | N/A | $219.37 K | $0 |
| 05/11/2023 | Q1 2023 | -$0.30 | -$0.27 | 0.03 | $220.00 K | $0 |
| 03/22/2023 | Q4 2022 | $0.25 | -$0.20 | -0.45 | N/A | $0 |
| 11/09/2022 | Q3 2022 | -$0.36 | -$0.16 | 0.2 | $5.66 M | $0 |
| 06/30/2022 | Q2 2022 | N/A | $0.05 | N/A | $5.61 M | $0 |
| 05/12/2022 | Q1 2022 | -$0.34 | -$0.30 | 0.04 | $5.30 M | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.30 | N/A | $5.17 M | $0 |
| 11/05/2021 | Q3 2021 | -$0.37 | -$0.27 | 0.1 | $5.09 M | $0 |
The conference call for InflaRx N.V.'s latest earnings report can be listened to online.
The conference call transcript for InflaRx N.V.'s latest earnings report can be read online.
InflaRx N.V. (:IFRX) has a recorded annual revenue of $29.33 K.
InflaRx N.V. (:IFRX) has a recorded net income of $-45,633,780.InflaRx N.V. has generated $-0.66 earnings per share over the last four quarters.
InflaRx N.V. (:IFRX) has a price-to-earnings ratio of -3.68 and price/earnings-to-growth ratio is -0.1.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED